Search research articles
Contact Us
Filters
Showing results (581-590 of 623) with videos related to
Page
of 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Research Communications
|
October 3, 2023
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced Sarcomas
Evan Rosenbaum, Kenneth Seier, Martina Bradic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2023
Stereotactic body radiation therapy for sarcoma pulmonary metastases
Emily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
Mrinal Gounder, Ved Desai, Deborah Kuk, et al.
Investigational New Drugs
|
August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
Ciara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Future Oncology (London, England)
|
December 22, 2025
A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Immunology Research
|
March 2, 2016
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
Jarushka Naidoo, Katja Schindler, Christiane Querfeld, et al.
Clinical Microbiology Reviews
|
June 9, 2021
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future
Nancy E Cornish, Nancy L Anderson, Diego G Arambula, et al.
Genome Announcements
|
November 25, 2016
Genome Sequence of Mycobacteriophage ErnieJ
Courtney J Robinson, Laricca Y London-Thomas, Leon A Dickson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Page
of 63
Search research articles
Search
Showing results (581-590 of 623) with videos related to
Sort By:
Page
of 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Research Communications
|
October 3, 2023
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced Sarcomas
Evan Rosenbaum, Kenneth Seier, Martina Bradic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2023
Stereotactic body radiation therapy for sarcoma pulmonary metastases
Emily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
Mrinal Gounder, Ved Desai, Deborah Kuk, et al.
Investigational New Drugs
|
August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
Ciara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Future Oncology (London, England)
|
December 22, 2025
A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Immunology Research
|
March 2, 2016
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
Jarushka Naidoo, Katja Schindler, Christiane Querfeld, et al.
Clinical Microbiology Reviews
|
June 9, 2021
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future
Nancy E Cornish, Nancy L Anderson, Diego G Arambula, et al.
Genome Announcements
|
November 25, 2016
Genome Sequence of Mycobacteriophage ErnieJ
Courtney J Robinson, Laricca Y London-Thomas, Leon A Dickson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Page
of 63